The role of non-contrast abbreviated MRI for secondary surveillance of hepatocellular carcinoma after curative treatment: prospective multicenter study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006395

Enrollment

210

Registered

2021-07-29

Start date

2021-09-01

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(non-contrast abbreviated MRI) : Participants will undergo non-contrast abbreviated MRI to detect secondary HCC after curative treatment, in addition to the contrast-enhanced CT, which is the cu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients giving written informed consent to participate in this study. 2) age between 20-year-old and 85-year-old 3) patients who underwent curative treatment using either surgical resection or local ablation for hepatocellular carcinoma (HCC) with more than a-2-year period of NED (no evidence of disease) 4) patients who have a schedule of contrast-enhanced CT to detect secondary HCC 5) No claustrophobia

Exclusion criteria

Exclusion criteria: 1) age below 20 or age over 85 2) patients with claustrophobia 3) patients with a cardiac pacemaker or cochlear implants

Design outcomes

Primary

Measure	Time frame
Sensitivity for detection of secondary HCC	—

Secondary

Measure	Time frame
Specificity for detection of secondary HCC;Positive predictive value for detection of secondary HCC;Negative predictive value for detection of secondary HCC	—

Countries

Korea, Republic of

Contacts

Public ContactDong Ho Lee

Seoul National University Hospital

dhlee.rad@gmail.com+82-2-2072-0348

Outcome results